|
HY-N7781-1mg
|
MedChemexpress LLC
|
(-)-(E)-Guggulsterone [CAS 39025-24-6]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-N7781-10mg
|
MedChemexpress LLC
|
(-)-(E)-Guggulsterone [CAS 39025-24-6]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-N7781-100mg
|
MedChemexpress LLC
|
(-)-(E)-Guggulsterone [CAS 39025-24-6]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-N7781-25mg
|
MedChemexpress LLC
|
(-)-(E)-Guggulsterone [CAS 39025-24-6]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-N7781-5mg
|
MedChemexpress LLC
|
(-)-(E)-Guggulsterone [CAS 39025-24-6]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-N7781-50mg
|
MedChemexpress LLC
|
(-)-(E)-Guggulsterone [CAS 39025-24-6]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-N7781-1mL
|
MedChemexpress LLC
|
(-)-(E)-Guggulsterone [CAS 39025-24-6] (10mM in DMSO)
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-114269-10mg
|
MedChemexpress LLC
|
(-)-(S)-B-973B [CAS 2244989-34-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-114269-100mg
|
MedChemexpress LLC
|
(-)-(S)-B-973B [CAS 2244989-34-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-114269-5mg
|
MedChemexpress LLC
|
(-)-(S)-B-973B [CAS 2244989-34-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-114269-50mg
|
MedChemexpress LLC
|
(-)-(S)-B-973B [CAS 2244989-34-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-114269-1mL
|
MedChemexpress LLC
|
(-)-(S)-B-973B [CAS 2244989-34-0] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N6012-10mg
|
MedChemexpress LLC
|
(-)-Alkannin [CAS 517-88-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N6012-5mg
|
MedChemexpress LLC
|
(-)-Alkannin [CAS 517-88-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13441-10mg
|
MedChemexpress LLC
|
(-)-Blebbistatin [CAS 856925-71-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-13441-100mg
|
MedChemexpress LLC
|
(-)-Blebbistatin [CAS 856925-71-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-13441-25mg
|
MedChemexpress LLC
|
(-)-Blebbistatin [CAS 856925-71-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-13441-5mg
|
MedChemexpress LLC
|
(-)-Blebbistatin [CAS 856925-71-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-13441-50mg
|
MedChemexpress LLC
|
(-)-Blebbistatin [CAS 856925-71-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-13441-1mL
|
MedChemexpress LLC
|
(-)-Blebbistatin [CAS 856925-71-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N0756A-1g
|
MedChemexpress LLC
|
(-)-Bornyl acetate [CAS 5655-61-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0756A-500mg
|
MedChemexpress LLC
|
(-)-Bornyl acetate [CAS 5655-61-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0756A-1mL
|
MedChemexpress LLC
|
(-)-Bornyl acetate [CAS 5655-61-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N0356-1mg
|
MedChemexpress LLC
|
(-)-Catechin gallate [CAS 130405-40-2]
|
|
Cancer-programmed cell death
|
|
|
HY-N0356-10mg
|
MedChemexpress LLC
|
(-)-Catechin gallate [CAS 130405-40-2]
|
|
Cancer-programmed cell death
|
|
